Viapath results

Viapath, the pathology provider previously known as GSTS Pathology, has reported a small increase in revenue against the ‘challenging backdrop’ faced by its NHS customers. The company, which restructured into three new entities at the end of 2014, produced a £0.2m increase in revenue to £97.3m in the year ended 31 December 2015. Cost of…

You must be a HM Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »